Choosing an appropriate salvage therapy for a patient with multiple myeloma
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2018.1515914
Abstract: The introduction of the proteasome inhibitor (PI) bortezomib (V) and immunomodulatory drugs (IMiDs) thalidomide (T) and lenalidomide (R/Revlimide) first in salvage, later in front-line multiple myeloma (MM) regimens has dramatically improved overall survival rates from… read more here.
Keywords: choosing appropriate; appropriate salvage; multiple myeloma; salvage ... See more keywords